2. OSD/Dry eye
25 million in US
Most common eye disease seen
$3.8 billion spent yearly
Ocular discomfort and vision problems
CL intolerance
New diagnostic techniques and treatment
options
3. Main Causes
Age > 50
Climate
Genetics, gender
Work environment
Smartphone use
Medications, systemic disease
LASIK
5. Diagnosis - established techniques
Symptoms vs. signs – not always consistent
Questionnaire, medical and rx hx.
Lacrimal river, lid margins, digital exp.
NaFl, Lissamine Green
Conjunctival chalasis, floppy eyelids test
Pingueculum and pterigium formation
Shirmer’s tests - phenol red thread test
Apposition of lids, blink freq. and quality
9. Current OSD management varies
based on type of dry eye
Dx: lipid vs aqueous deficiency
85% is MGD – lipid deficiency, Demodex
Most aqueous deficiency is found in
females, immune disorders or with the use
of opiods, Accutane, diuretics, beta
blockers, anti-depressives, anti-anxiety
meds and antihistamines
11. MGD/evaporative dry eye therapy
Lid/gland heat, MG expression, hygiene
PF oil based lubricants, Omega 3 FA
Blink training
Z pack po +/-Azasite or Tobradex gtts
Avenova and/or Cliradex
Moisture chamber glasses and workplace
changes
Plugs, Restasis, Maskin procedure
12. Meibomian Gland Dysfunction
LIPOFLOW - $1300 to $2000
MiBO - $500, three treatments over 6-8 wks
IPL – Intense Pulsed Light
Home therapy – Bruder hot mask/ massage/
hygiene
13. Keys to success in a dry eye
practice
Manage expectations/patient education
Long term therapy for a chronic progressive
disease
Minimize worsening, maximize comfort and
vision
Start with least expensive therapy not already
tried
Give patients hope and options for advanced
care if needed